Understanding the biology of melanoma heterogeneity with a goal to improve therapies. #tumor_spheroids #microscopy #scitweets #FUCCI
Australia
Joined August 2018
- Tweets862
- Following415
- Followers862
- Likes2.7K
Hidden Architecture of Resistance: The Extracellular Matrix in Melanom… sciencedirect.com/science/ar…
immedicohospitalario.es/noti…
Zeng, Gandini et al. (2026)
Using targeted therapy to promote a pro-inflammatory tumour microenvironment and anti-tumour immune response in high grade serous ovarian cancer.
Br J Cancer 134: 1830–1840
rdcu.be/fokWq
Zeng, Gandini et al. (2026)
Using targeted therapy to promote a pro-inflammatory tumour microenvironment and anti-tumour immune response in high grade serous ovarian cancer.
Br J Cancer 134: 1830–1840
PMID: 41946828; doi: 10.1038/s41416-026-03416-y
rdcu.be/fokWq
Zeng, Gandini et al. (2026)
Using targeted therapy to promote a pro-inflammatory tumour microenvironment and anti-tumour immune response in high grade serous ovarian cancer.
Br J Cancer 134: 1830–1840
PMID: 41946828; doi: 10.1038/s41416-026-03416-y
Hui SY, Jain R, Haass NK, Weninger W, Tikoo S, Guo D (2026)
The Emerging Melanoma Management: Historical Perspective to Future Directions.
Cancers 18: 968
PMID: 41899570; doi: 10.3390/cancers18060968https://www.mdpi.com/3792592
Hot off the press! Congrats to Sanket, @LukeJohnsonLab and their team and collaborators - fantastic work!
Raut SB, Joly F, Haass NK, Eri R, Canales JJ, Benedek DM, Ursano RS, Johnson LR (2024). Transl Psychiatry 14: 492
doi: doi.org/10.1038/s41398-024-0…
NHMRC results are out "Under Embargo". Yes we know that the Australian Government is only interested in mining and footy, but not in science and the arts. So, why Embargo?!
Do you remember the four years (Jan 2017-Jan 2021) of chaos, destruction and disaster? Not again!
If you love democracy, unity, human rights, peace and our precious environment, please vote for Kamala Harris!
Today!
@HaassLab is a clinical scientist and academic leader at #FrazerInstUQ @UQMedicine @TRI_info. Hear his talk ‘Re-sensitisation of resistant patients to immune checkpoint therapy’ at the 2024 MASC Trials ASM, 24 October 2024, Sydney. Register: masc.org.au/asm-2024/
@MelanomaAus
Haass_Melanoma_lab retweeted
TRI explored melanoma, the immune system, prostate, bladder and childhood brain cancer - as part of a mini-symposium today. Thanks Dr Mitchell Lawrence at @MonashUni, @srilakshmisri13, @HaassLab, Elysse Morris, Dr Liam O'Brien, @OzEDW, @BockNat. @QUT, @UQ_News, @MaterResearch.
Long week: #FrazerInstUQ @UQMedicine HDR retreat on Monday and Tuesday on Minjerribah, and Skin Cancer 2024 conference from Wednesday through to Sunday at the BCEC! skincancer2024.org/
Haass_Melanoma_lab retweeted
🎁Interested in reading more about the study? Here is the Research Briefing describing the authors' and an expert's view, but also the editor's perspective on the findings and their importance. #microtubule #mechanobiology
👉🏽rdcu.be/dTAaS
nature.com/articles/s41556-0…
💫NEW: @SamStehbens, @robertr33 & co show that during 3D #CellMigration, compression recruits cytoplasmic linker-associated proteins to #microtubules, which coordinate nuclear positioning and contractility in confined migration.
👉🏼rdcu.be/dTz7u
nature.com/articles/s41556-0…
IUBP-MEPSA World Congress, 25th-30th August 2024, Perth.
We certainly cannot say that we didn't know better back then.
Haass_Melanoma_lab retweeted
Team science wins again. This project epitomises what can be achieved when the right group of people are proud together. Huge congratulations to @MelanomaACEMID team!!
🏆 ACRF Australian Centre of Excellence in Melanoma Imaging and Diagnosis @MelanomaACEMID @UQMedicine is awarded the @BizEventsPerth Eureka Prize for Excellence in Interdisciplinary Scientific Research. #EurekaPrizes
Learn more: youtu.be/VV7x9SlGupw
IUBP-MEPSA World Congress 2024, Perth.
Session "Melanoma heterogeneity and therapeutic approaches" on the 27th August 2024. @TheStarkLab, #FrazerInstUQ, @UQMedicine; @vivianchualah, @EdithCowanUni; Peter Lau, @PerkinsComms; @HaassLab, #FrazerInstUQ, @UQMedicine
#FrazerInstUQ @UQMedicine HDR Minisymposium today. Great talks, great discussion. People's choice best talk award goes to Marion Barros @SimpsonTeamUQ. Runner-up was Daniel Butcher @YUmmunology. Congratulations!
Haass_Melanoma_lab retweeted
@HaassLab is a clinical scientist and academic leader at #FrazerInstUQ @UQMedicine @TRI_info. Hear his talk ‘Re-sensitisation of resistant patients to immune checkpoint therapy’ at the 2024 MASC Trials ASM, 24 October 2024, Sydney. Register: masc.org.au/asm-2024/
@MelanomaAus
Haass_Melanoma_lab retweeted
@HaassLab is a clinical scientist and academic leader at #FrazerInstUQ @UQMedicine @TRI_info. Hear his talk ‘Re-sensitisation of resistant patients to immune checkpoint therapy’ at the 2024 MASC Trials ASM, 24 October 2024, Sydney. Register: masc.org.au/asm-2024/
@MelanomaAus
Haass_Melanoma_lab retweeted
Great talk by A/Prof Aideen McInerney-Leo, from UQ, about the importance of Mainstreaming Melanoma Genetic Testing in Australia. @Amcinerneyleo @AsdrResearch @CTSR_USyd
